Klaviyo (NYSE: KVYO) co-CEO Bialecki sells 206,827 shares in 10b5-1 plan
Rhea-AI Filing Summary
Klaviyo, Inc. co-CEO Andrew Bialecki converted 206,827 shares of Series B Common Stock into Series A Common Stock and then sold 206,827 Series A shares in open-market transactions around $19.96 and $19.34 per share under a pre-arranged Rule 10b5-1 trading plan. After these trades, he reports 68,344,118 Series B shares held directly and maintains additional indirect interests in shares held by several 2023 trusts and by his spouse, for which he disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Planned sales by Klaviyo's co-CEO are small relative to his disclosed stake.
Co-CEO Andrew Bialecki converted 206,827 Series B shares into Series A and sold the same number of Series A shares at weighted average prices near $19.96 and $19.34. The transactions are explicitly described as occurring under a Rule 10b5-1 trading plan adopted on May 20, 2025, indicating they were pre-scheduled rather than opportunistic.
Following the sales, he still holds 68,344,118 Series B shares directly and has indirect interests in additional shares through 2023 trusts and his spouse, where beneficial ownership is disclaimed except for any pecuniary interest. Given the remaining holdings and the pre-planned nature of the trades, this filing looks like routine liquidity management rather than a change in long-term outlook.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series B Common Stock | 206,827 | $0.00 | -- |
| Conversion | Series A Common Stock | 206,827 | $0.00 | -- |
| Sale | Series A Common Stock | 206,127 | $19.96 | $4.11M |
| Sale | Series A Common Stock | 700 | $19.34 | $14K |
| holding | Series B Common Stock | -- | -- | -- |
| holding | Series B Common Stock | -- | -- | -- |
| holding | Series B Common Stock | -- | -- | -- |
| holding | Series B Common Stock | -- | -- | -- |
Footnotes (1)
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.375 to $20.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.28 to $19.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held by the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Shares held by the Elizabeth L. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose. Shares held by the Andrew P. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
